» Articles » PMID: 21740677

The Impact of Combined Pulmonary Fibrosis and Emphysema on Mortality

Overview
Specialty Pulmonary Medicine
Date 2011 Jul 12
PMID 21740677
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Setting: The impact on patient mortality of combined pulmonary fibrosis and emphysema (CPFE) compared with emphysema alone has never been investigated.

Objective: To elucidate whether CPFE has an impact on overall mortality over that of emphysema alone.

Design: We screened patients who underwent chest computed tomography (CT) scans during the period from 1 January 2001 to 31 December 2005 in a tertiary referral hospital. Patients who had both emphysema and pulmonary fibrosis, thus meeting the inclusion criteria, were defined as CPFE. Controls with emphysema alone who were matched for age, sex and the date of CT scan were randomly selected. Cox proportional regression analysis was performed to verify whether CPFE is associated with increased overall mortality.

Results: We found 135 CPFE cases. In the multivariable Cox regression stratified by the presence of comorbid malignancy, CPFE had five times higher mortality risk (adjusted HR 5.10, 95%CI 1.75-14.9) in non-malignant cases, and showed a statistically insignificant trend for higher mortality risk (adjusted HR 1.70, 95%CI 0.94-2.51) in the malignant cases after adjusting for forced vital capacity, height and hypertension.

Conclusion: CPFE is not rare and CPFE patients had a higher overall mortality risk than emphysema-only patients.

Citing Articles

Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension.

Gayen S, Pescatore J, Bittner M, Naranjo M, Criner G, Weaver S BMC Pulm Med. 2025; 25(1):69.

PMID: 39923026 PMC: 11807298. DOI: 10.1186/s12890-025-03538-8.


Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study.

Zhou A, Zhang X, Lu R, Peng W, Wang Y, Tang H Heliyon. 2024; 10(15):e35099.

PMID: 39165953 PMC: 11333912. DOI: 10.1016/j.heliyon.2024.e35099.


Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases.

Labaki W, Agusti A, Bhatt S, Bodduluri S, Criner G, Fabbri L Am J Respir Crit Care Med. 2024; 210(3):281-287.

PMID: 38843079 PMC: 11348973. DOI: 10.1164/rccm.202402-0407PP.


An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis.

Ni H, Wei Y, Yang L, Wang Q BMC Pulm Med. 2023; 23(1):221.

PMID: 37344866 PMC: 10283193. DOI: 10.1186/s12890-023-02425-4.


Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.

Gredic M, Karnati S, Ruppert C, Guenther A, Avdeev S, Kosanovic D Cells. 2023; 12(9).

PMID: 37174678 PMC: 10177208. DOI: 10.3390/cells12091278.